 causal relationship transdermal scopolamine seizures methodologic lessons pharmacoepidemiology case reports use transdermal scopolamine subsequent development seizures retrospective cohort study computerized Medicaid data Patients transdermal scopolamine patients diphenhydramine meclizine prochlorperazine promethazine four-fold increased risk seizures transdermal scopolamine use claims data primary medical records patients seizures transdermal scopolamine seizures drug seizures original finding result use transdermal scopolamine dizziness rule seizures coding system diagnoses data existence association seizures use transdermal scopolamine addition study usefulness pharmacoepidemiology studies drug safety importance primary medical records pharmacoepidemiologic studies claims data